Christine Booth, MD
- Call 216.444.2845
Cleveland Clinic Main Campus
Treatment & Services
- Cancer Center
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.View All Plans
About Christine Booth, MD
Christine Noga Booth, MD, is an associate professor of pathology at the Cleveland Clinic Lerner College of Medicine. Dr. Booth is also Co-Section Head of Cytopathology in the Institute of Pathology and Laboratory Medicine at Cleveland Clinic.
She is actively involved in the cytopathology, fine needle aspiration and breast surgical pathology services. She is currently Chair of the Cytopathology Committee and a member of the Council on Scientific Affairs for the College of American Pathologists and a member of the Scientific Program Committee at the American Society of Cytopathology.
Education & Professional Highlights
Education & Fellowships
Fellowship - Allegheny General Hospital-Suburban Campus
Pittsburgh, PA USA
Residency - Cleveland Clinic
Anatomic and Clinical Pathology
Cleveland, OH USA
Medical Education - Loyola University Chicago Stritch School of Medicine
Chicago, IL USA
Undergraduate - Fairfield University
Fairfield, CT USA
- Pathology - Anatomic & Clinical Pathology
- Pathology - Pathology Recertification
- Pathology - Cytopathology
breast pathology, cytopathology, fine needle aspiration
Research & Publications
See publications for Christine Booth, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/3/2023, Dr. Booth has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.